CHO YL[au] - Search Results

Year	Number of Results
1991	1
1993	1
1995	1
1996	1
1997	1
2000	1
2001	2
2003	3
2004	5
2005	6
2006	6
2007	1
2008	3
2009	9
2010	13
2011	7
2012	4
2013	6
2014	5
2015	19
2016	5
2017	12
2018	14
2019	9
2020	8
2021	5
2022	9
2023	6
2024	13
2025	5

1

Particulate matter-induced lung cancer metastasis is inhibited by ginsenoside Rg3.

Lee YJ, Park SH, Oh B, Yoon SJ, Lee SJ, Choi S, Kim MJ, Kim J, Cho YL, Kim W, Ku BJ, Park YJ. Lee YJ, et al. Among authors: cho yl. J Environ Sci (China). 2025 Dec;158:60-71. doi: 10.1016/j.jes.2025.01.022. Epub 2025 Jan 25. J Environ Sci (China). 2025. PMID: 40841037 Free article.

2

Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.

Minja LT, van der Feltz I, Manyama C, Mpagama S, Mhimbira F, Noreña I, Sebe M, Rassool M, Wallis RS, Ntinginya N, Liyoyo A, Mbeya B, Wagnerberger L, Zumba T, Peter DD, Makkan H, Sloan DJ, Brake LT, Schildkraut JA, Aarnoutse R, McHugh TD, Wildner L, Boeree MJ, Geiter L, Cho YL, Aldana BH, Phillips PPJ, Hoelscher M, Svensson EM, Heinrich N; PanACEA consortium. Minja LT, et al. Among authors: cho yl. Lancet Infect Dis. 2025 Nov;25(11):1219-1229. doi: 10.1016/S1473-3099(25)00289-0. Epub 2025 Jul 8. Lancet Infect Dis. 2025. PMID: 40645198 Free article. Clinical Trial.

3

Structural and functional insights of AmpG in muropeptide transport and multiple β-lactam antibiotics resistance.

Chang N, Kim H, Kim U, Cho Y, Yoo Y, Lee H, Kim JW, Kim MS, Lee J, Cho YL, Kim K, Yong D, Cho HS. Chang N, et al. Among authors: cho yl. Nat Commun. 2025 Jul 1;16(1):5744. doi: 10.1038/s41467-025-61169-3. Nat Commun. 2025. PMID: 40593790 Free PMC article.

4

Glucose-6-phosphate dehydrogenase regulates mitophagy by maintaining PINK1 stability.

Cho YL, Tan HWS, Yang J, Kuah BZM, Lim NSY, Fu N, Bay BH, Ling SC, Shen HM. Cho YL, et al. Life Metab. 2024 Dec 13;4(1):loae040. doi: 10.1093/lifemeta/loae040. eCollection 2025 Feb. Life Metab. 2024. PMID: 39872984 Free PMC article.

5

Comparative pharmacokinetics study of two tablet formulations of delpazolid, a novel oxazolidinone class antibiotic.

Koh J, Khwarg J, Cho YL, Yu KS, Chung JY. Koh J, et al. Among authors: cho yl. Transl Clin Pharmacol. 2024 Dec;32(4):216-224. doi: 10.12793/tcp.2024.32.e18. Epub 2024 Dec 18. Transl Clin Pharmacol. 2024. PMID: 39801777 Free PMC article.

6

MT-100, a human Tie2-agonistic antibody, improves penile neurovasculature in diabetic mice via the novel target Srpx2.

Liu FY, Cho YL, Fridayana FR, Niloofar L, Vo MN, Huang Y, Limanjaya A, Kwon MH, Ock J, Lee SJ, Yin GN, Lee NK, Ryu JK. Liu FY, et al. Among authors: cho yl. Exp Mol Med. 2025 Feb;57(1):104-117. doi: 10.1038/s12276-024-01373-1. Epub 2025 Jan 1. Exp Mol Med. 2025. PMID: 39741183 Free PMC article.

7

Coactivation of Tie2 and Wnt signaling using an antibody-R-spondin fusion potentiates therapeutic angiogenesis and vessel stabilization in hindlimb ischemia.

Hwang B, Jeon MY, Jang JH, Cho YL, Lee DG, Min JK, Lee J, Park JG, Noh JH, Yang W, Lee NK. Hwang B, et al. Among authors: cho yl. MAbs. 2024 Jan-Dec;16(1):2435478. doi: 10.1080/19420862.2024.2435478. Epub 2024 Nov 28. MAbs. 2024. PMID: 39607038 Free PMC article.

8

In Vivo Evaluation of ⁶⁸Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model.

Park JY, Cho YL, Lee TS, Lee D, Kang JH, Lim S, Lee Y, Lim JH, Kang WJ. Park JY, et al. Among authors: cho yl. Pharmaceutics. 2024 Jun 16;16(6):814. doi: 10.3390/pharmaceutics16060814. Pharmaceutics. 2024. PMID: 38931935 Free PMC article.

9

Speciation, phytoavailability, and accumulation of toxic elements and sulfur by humic acid-fertilized lemongrass and common sage in a sandy soil treated with heavy oil fly ash: A trial for management of power stations wastes.

Al-Solaimani SG, Al-Qureshi A, Hindi SS, Ibrahim OH, Mousa MAA, Cho YL, Hassan NEE, Liu YT, Wang SL, Antoniadis V, Rinklebe J, Shaheen SM. Al-Solaimani SG, et al. Among authors: cho yl. Sci Total Environ. 2024 Oct 1;945:173998. doi: 10.1016/j.scitotenv.2024.173998. Epub 2024 Jun 18. Sci Total Environ. 2024. PMID: 38901575

10

Accumulation and bio-oxidation of arsenite mediated by thermoacidophilic Cyanidiales: innate potential biomaterials toward arsenic remediation.

Cho YL, Tzou YM, Assakinah A, Than NAT, Yoon HS, Park SI, Wang CC, Lee YC, Hsu LC, Huang PY, Liu SL, Liu YT. Cho YL, et al. Bioresour Technol. 2024 Aug;406:130912. doi: 10.1016/j.biortech.2024.130912. Epub 2024 May 29. Bioresour Technol. 2024. PMID: 38821424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Results by year